ATAI Life Sciences BV
ATAIInsider trades and stock quote 2024-2026
All insider trades at ATAI Life Sciences BV
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/20/2026 | Sell | Craig, Kevin James | Chief Medical Officer | $5.0 | $212,895 |
| 3/20/2026 | Sell | Craig, Kevin James | Chief Medical Officer | $3.6 | $355,000 |
| 1/2/2026 | Sell | Feilding-Mellen, Cosmo | Director | $3.9 | $154,377 |
| 8/14/2025 | Buy | Apeiron Investment Group Ltd. | Ten Percent Owner | $2.2 | $19,000,000 |
| 3/24/2025 | Buy | Apeiron Investment Group Ltd. | Ten Percent Owner | $1.4 | $2,520,000 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)